Abstract
Eicosanoids are highly active lipid mediators in physiologic and pathologic processes, with their effects ranging from cytoprotection and vasoactivity to modulation of inflammatory and proliferative reactions. Generation of eicosanoids can be affected by changes in the pools of their precursors, the long-chain polyunsaturated fatty acids (LCPUFA). Thus, dietary interventions such as supplementation of infant formula with specific n−3 and n−6 LCPUFA will alter formation as well as activity of the eicosanoids produced. This report summarizes the results and discussion of the workshop on “Eicosanoids and Polyunsaturated Fatty Acids in Infants”. The intention of the workshop organizers was to give an overview of the role of eicosanoids in physiological and pathophysiological processes in infants, to discuss the implications that an increased n−3 and n−6 LCPUFA intake may have on eicosanoid genration, and to point out open questions and controversies for future research.
Similar content being viewed by others
Abbreviations
- CNS:
-
central nervous system
- HETE:
-
hydroxyeicosatetraenoic acid
- LCPUFA:
-
long chain polyunsaturated fatty acid
- LT:
-
leukotriene
- PG:
-
prostaglandin
- Tx:
-
thromboxane
References
Hershman, H.R. (1996) Prostaglandin Synthase 2, Biochim. Biophys. Acta 1299, 125–140.
Henderson, R.H. (1994) The Role of Leukotrienes in Inflammation, Ann. Int. Med. 121, 684–697.
McGiff, J.C. (1991) Cytochrome P450 Metabolism of Arachidonic Acid, Annu. Rev. Pharmacol. Toxicol. 31, 339–369.
Clària, J., and Serhan, C.N. (1995) Asprin Triggers Previously Undescribed Bioactive Eicosanoids by Human Endothelial Cell-Leukocyte Interactions, Proc. Natl. Acad. Sci. USA 92, 9475–9479.
Stenke, L., Reizenstein, P., and Lindgren, Å. (1994) Leukotrienes and Lipoxins—New Potential Performers In the Regulation of Human Myelopoiesis, Leukemia Res. 18, 727–732.
Khan, W.A., Blobe, G.C., and Hannun, Y.A. (1995) Arachidonic Acid and Free Fatty Acids as Second Messengers and the Role of Protein Kinase C, Cell. Signal 7, 171–184.
Leaf, A., and Weber, P.C. (1988) Cardiovascular Effects of n−3 Fatty Acids, N. Engl. J. Med. 318, 549–557.
Weber, P.C., Fischer, S., von Schacky, C., Lorenz, R., and Strasser, T. (1986) The Conversion of Dietary Eicosapentaenoic Acid to Prostanoids and Leukotrienes in Man, Prog. Lipid Res. 25, 273–276.
Knapp, H.R. (1995) Omega-3 Fatty Acids in Respiratory Diseases: A Review, J. Am. Coll. Nutr. 14, 18–23.
Seyberth, H.W., Knapp, G., Wolf, D., and Ulmer, H.E. (1983) Introduction of Plasma Indomethacin Level Monitoring and Evaluation of an Effective Threshold Level in Very Low Birthweight Infants with Symptomatic Patent Ductus Arteriosus, Eur. J. Pediatr. 141, 71–76.
Leonhardt, A., Busch, C., Schweer, H., and Seyberth, H.W. (1992) Reference Intervals and Developmental Changes in Urinary Prostanoid Excretion in Healthy Newborns, Infants and Children, Acta Paediatr. Scand. 81, 191–196.
Uauy, R., Hoffmann, D.R., Birch, E.E., Birch, D.G., Jameson, D.M., and Tyson, J. (1994) Safety and Efficacy of Omega-3 Fatty Acids in the Nutrition of Very Low Birth Weight Infants: Soy Oil and Marine Oil Supplementation of Formula, J. Pediatr. 124, 612–620
Juzan, M., Hostein, I., and Gualde, N. (1992) Role of Thymus-Eicosanoids in the Immune Response, Prostaglandins Leukotrienes Essent. Fatty Acids 46, 247–255.
Roper, R.L., and Phipps, R.P. (1992) Prostaglandin E2 and cAMP Inhibit B Lymphocyte Activation and Simultaneously Promote IgE and IgG1 Synthesis, J. Immunol. 149, 2984–2991.
Goetzl, E.J., Songhzu, A., and Smith, W.L. (1995) Specificity of Expression and Effects of Eicosanoid Mediators in Normal Physiology and Human Diseases, FASEB J. 9, 1051–1058.
Claesson, H.-E., Odlander, B., and Jakobsson, P.-J. (1992) Leukotriene B4 in the Immune Systems, Int. J. Immunopharmacol. 14, 441–449.
Knapp, H.R. (1990) Prostaglandins in Human Semen During Fish Oil Ingestion: Evidence for in vivo Cyclooxygenase Inhibition and Appearance of Novel Trienoic Compounds, Prostaglandins 39, 407–423.
Lawrence, R., and Sorrell, T. (1993) Eicosapentaenoic Acid in Cystic Fibrosis: Evidence of a Pathogenetic Role for Leukotriene B4, Lancet 342, 465–469.
Lawrence, R.H., and Sorrell, T.C. (1994) Eicosapentaenoic Acid Modulates Neutrophil Leukotriene B4 Receptor Expression in Cystic Fibrosis, Clin. Exp. Immunol. 98, 12–16.
Kremer, J.M. (1991) Clinical Studies of Omega-3 Fatty Acid Supplementation in Patients Who Have Rheumatoid Arthritis, Rheum. Dis. Clin. North Am. 17, 391–402.
Donadio, J.V., Bergstrahl, E.J., Offord, K.P., Spencer, D.C., Holley, K.E., and the M.N.C. Group (1994) A Controlled Trial of Fish Oil In IgA Nephropathy, N. Engl. J. Med. 331, 1194–1199.
Homan van der Heide, J.J., Bilo, H.J.G., Donker, J.M., Wilmink, J.J., and Tegzess, A.M. (1993) Effect of Dietary Fish Oil on Renal Function and Rejection in Cyclosporine-Treated Recipients of Renal Transplants, N. Engl. J. Med. 329, 769–773.
Kooijmans-Coutinho, M.F., Rischen-Vos, J., Hermans, J., Arndt, J.-W., and van der Woude, F.J. (1996) Dietary Fish Oil in Renal Transplant Recipients Treated with Cyclosporin-A: No Beneficial Effects Shown, J. Am. Soc. Nephrol. 7, 513–518.
Clark, W.F., and Parbtani, A. (1994) Omega-3 Fatty Acid Supplementation in Clinical and Experimental Lupus Nephritis, Am. J. Kidney Dis. 23, 644–647.
Robinson, D.R., Prickett, J.D., Makoul, G.T., Steinberg, A.D., and Calvin, R.B. (1986) Dietary Fish Oil Reduces Progression of Established Renal Disease in (NZB×NZW)F1 Mice and Delays Renal Disease in BXSB and MRL/I Strains, Arthritis Rheum. 29, 539–546.
Fernandes, G., Bysani, C., Venkatraman, J.T., Tomar, V., and Zhao, W. (1994) Increased TGF-β and Decreased Oncogene Expression by ω-3 Fatty Acids in the Spleen Delays Onset of Autoimmune Disease in B/W Mice, J. Immunol. 152, 5979–5987.
Meydani, S.N. (1992) Modulation of Cytokine Production by Dietary Polyunsaturated Fatty Acids, Proc. Soc. Exp. Biol. Med. 200, 189–193.
Caygill, C.P.J., Charlett, A., and Hill, M.J. (1996) Fat, Fish Oil and Cancer, Br. J. Cancer 74, 159–164.
Sassen, L.M.A., Lamers, J.M.J., and Verdouw, P.D. (1994) Fish Oil and the Prevention and Regression of Atherosclerosis, Cardiovascs. Drugs Therapy 8, 179–191.
Olsen, S.F., Sørensen, J.D., Secher, N.J., Hedegaard, M., henriksen, T.B., Hansen, H.S., and Grant, A. (1992) Randomised Controlled Trial of Effect of Fish-Oil Supplementation on Pregnancy Duration, Lancet 339, 1003–1007.
Innis, S.M., Akrabawi, S.S., Diersen-Schade, D.A., Dobson, M.V., and Guy, D.G. (1997) Visual Acuity and Blood Lipids in Term Infants Fed Human Milk or Formulae, Lipids 32, 63–72.
Auestad, N., Montalto, M.B., Hall, R.T., Fitzgerald, K.M., Wheeler, R.E., Connor, W.E., Neuringer, M., Connor, S.L., Taylor, J.A., and Hartmann, E.F. (1997) Visual Acuity, Erythrocyte Fatty Acid Composition, and Growth in Term Infants Fed Formulas with Long Chain Polyunsaturated Fatty Acids for One Year. Ross Pediatric Lipid Study, Pediatr. Res. 41, 1–10.
Jensen, C.L., Prager, T.C., Fraley, J.K., Chen, H., Anderson, R.E., and Heird, W.C. (1997) Effect of Dietary Linoleic/alpha-Linolenic Acid Ratio on Growth and Visual Function of Term Infants, J. Pediatr. 131, 200–209.
Carlson, S.E., Cooke, R.J., Werkman, S.H., and Tolley, E.A., (1992) First Year Growth in Preterm Infants Fed Standard Compared to Marine Oil n−3 Supplemented Formula, Lipids 27, 901–907.
Carlson, S.E. (1996) Arachidonic Acid Status of Human Infants: Influence of Gestational Age at Birth and Diets with Very Long Chain n−3 and n−6 Fatty Acids, J. Nutr. 126 (4 Suppl.), 1092S-1098S.
Koletzko, B., and Braun, M. (1991) Arachidonic Acid and Early Human Growth: Is There a Relation?, Ann. Nutr. Metab. 35, 128–131.
Carlson, S.E., Werkman, M.J., and Tolley, E.A. (1996) Effect of Long-Chain n−3 Fatty Acid Supplementation on Visual Acuity and Growth in Pretern Infants with and Without Bronchopulmonary Dysplasia, Am. J. Clin. Nutr. 63, 687–697.
Leaf, A.A., Leighfield, M.J., Costeloe, K.L., and Crawford, M.A. (1992) Long Chain Polyunsaturated Fatty Acids and Fetal Growth, Early Hum. Dev. 30, 183–191.
Sellmayer, A., Uedelhoven, W.M., Weber, P.C., and Bonventre, J.V. (1991) Endogenous Non-cyclooxygenase Metabolites of Arachidonic Acid Modulate Growth and mRNA Levels of Immediate-Early Response Genes in Rat Mesangial Cells, J. Biol. Chem. 266, 3800–3807.
Handler, J.A., Danilowicz, R.M., and Eling, T.E. (1990) Mitogenic Signaling by Epidermal Growth Factor (EGF), but Not Platelet-Derived Growth Factor, Requires Arachidonic Acid Metabolism In BALB/c 3T3 Cells, J. Biol. Chem. 265, 3669–3673.
Lupulescu, A. (1996) Prostaglandins, Their Inhibitors and Cancer, Prostaglandins Leukotrienes Essent. Fatty Acids. 54, 83–94.
Danesch, U., Weber, P.C., and Sellmayer, A. (1996) Differential Effects of n−6 and n−3 Polyunsaturated Fatty Acids on Cell Growth and Early Gene Expression in Swiss 3T3 Fibroblasts, J. Cell. Physiol. 168, 618–624.
Scales, W.E., and Kluger, M.J. (1987) Effect of Antipyretic Drugs on Circadian Rhythm in Body Temperature of Rats, Am. J. Physiol. 253, R306-R313.
Davis, G.W., and Murphey, R.K. (1994) Long-Term Regulation of Short-Term Transmitter Release Properties: Retrograde Signalling and Synaptic Development, Trends Neurosci. 17, 9–13.
Horrobin, D.F., and Manku, M.S. (1980) Possible Role of Prostaglandin E1 in the Affective Disorders and in Alcoholism, Br. Med. J. 280, 1361–1366.
Onoe, H., Ueno, R., Fuita, I., Nishino, H., Oomura, Y., and Hayaishi, O. (1988) Prostaglandin D2, a Cerebral Sleep-Inducting Substance in Monkeys, Proc. Natl. Acad. Sci. USA 85, 4082–4086.
Srikantha, S., Matsumura, H., Kubo, E., Kawase, K., Takahata, R., Serhan, C.N., and Hayaishi, O. (1994) Effects of Prostaglandin D2, Lipoxins and Leukotrienes on Sleep and Brain Temperature of Rats, Prostaglandins Leukotrienes Essent. Fatty Acids 51, 87–93.
Matsumura, H., Honda, K., Goh, Y., Ueno, R., Sakai, T., Inoue, S., and Hayaishi, O. (1989) Awaking Effect of Prostaglandin E2 in Freely Moving Rats, Brain Res. 481, 242–249.
Fagioli, L., Baroncini, P., Ricour, C., and Salzarulo, P. (1989) Decrease of Slow-Wave Sleep in Children with Prolonged Absence of Essential Lipids Intake, Sleep 12, 495–499.
Huang, M.-C., and Craig-Schmidt, M.C. (1996) Arachidonate and Docosahexaenoate Added to Infant Formula Influence Fatty Acid Composition and Subsequent Eicosanoid Production in Neonatal Pigs, J. Nutr. 126, 2199–2208.
Griswold, D.E., and Adams, J.L. (1996) Constitutive Cyclooxygenase (COX-1) and Inducible Cyclooxygenase (COX-2): Rationale for Selective Inhibition and Progress to Date, Medicin. Res. Rev. 16, 181–206.
Mayatepek, E., and Hoffmann, G.F. (1995) Leukotrienes: Biosynthesis, Metabolism and Pathophysiologic Significance, Ped. Res. 37, 1–9.
Thien, F.C.K., and Walters, E.H. (1995) Eicosanoids and Asthma, Prostaglandins Leukotrienes Essent. Fatty Acids 52, 271–288.
Israels, S.J., Odaibo, F.S., Robertson, C., McMillan, E.M., and McNicol, A. (1997) Defrelent Thromboxane Synthesis and Response in Platelets from Premature Infants, Pediatr. Res. 41, 218–223.
Cheromcha, D.P., and Hyman, P.E. (1988) Neonatal Necrotizing Enterocolitis. Inflammatory Bowel Disease of the Newborn, Dig. Dis. Sci. 33, (3 Suppl.), 78S-84S.
Stenmark, K.R., James, S.L., Voelkel, N.F., Toews, W.H., Reeves, J.T., and Murphy, R.C. (1983) Leukotrienes C4 and D4 in Neonates with Hypoxemia and Pulmonary Hypertension, N. Engl. J. Med. 309, 77–80.
Groneck, P., Gotze-Speer, B., Oppermann, M., Eiffert, H., and Speer, C.P. (1994) Association of Pulmonary Inflammation and Increased Microvascular Permeability During the Development of Bronchopulmonary Dysplasia: A Sequential Analysis of Inflammatory Mediators in Respiratory Fluids of High-Risk Preterm Neonates, Pediatrics. 93, 712–718.
Watterberg, K.L., Demers, L.M., Scott, S.M., and Murphy, S. (1996) Chorloamnionitis and Early Lung Inflammation in Infants in Whom Bronchopulmonary Dysplasia Develops, Pediatrics 97, 210–215.
Guignard, J.P., Gouyon, J.B., and John, E.G. (1991) Vasoactive Factors in the Immature Kidney, Pediatr. Nephrol. 5, 443–446.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Sellmayer, A., Koletzko, B. Long-chain polyunsaturated fatty acids and eicosanoids in infants-physiological and pathophysiological aspects and open questions. Lipids 34, 199–205 (1999). https://doi.org/10.1007/s11745-999-0354-z
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11745-999-0354-z